Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1145 (24 May), doi:10.1136/bmj.326.7399.1145-a
| The first 100% of the full text of this article appears below. |
EDITORI concur with Wright et al's unease about polypharmacy.1 Consultants with narrower interests simply bolt on their particular care package if the patient is referred in their direction.
Dare I suggest that general practitioners are specialists in "multiple morbidity," which may often include persistent unexplained physical symptoms and some degree of somatisation. Could it be incumbent on us as general practitioners to edit the Leviathan of the modern prescription without recourse to our bewildered hospital colleagues?
Are we ready to admit that the dangers of polypharmacy usually outweigh the small absolute benefits of each drug? Half our patients will not manage to comply in any case. Perhaps they are the safer.
David J Young, general practitioner principal
Derby DE2 7RJ David.J.Young@btinternet.com